{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:13:54Z","timestamp":1759331634085,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jfo.2022.09.033","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T21:27:06Z","timestamp":1675805226000},"page":"356-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Screening for toxic retinopathy due to antimalarial drugs in Tunisia"],"prefix":"10.1016","volume":"46","author":[{"given":"I.","family":"Zone-Abid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Maaloul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Halouani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Frikha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Marzouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Bahloul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Trigui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2022.09.033_bib0110","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1016\/j.lpm.2014.03.007","article-title":"Hydroxychloroquine: a multifaceted treatment in lupus","volume":"43","author":"Costedoat-Chalumeau","year":"2014","journal-title":"Presse Med"},{"key":"10.1016\/j.jfo.2022.09.033_bib0115","doi-asserted-by":"crossref","first-page":"164","DOI":"10.5114\/reum.2018.76904","article-title":"Antimalarials\u2013are they effective and safe in rheumatic diseases?","volume":"56","author":"Ha\u0142adyj","year":"2018","journal-title":"Rheumatol"},{"key":"10.1016\/j.jfo.2022.09.033_bib0120","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4103\/idoj.IDOJ_280_20","article-title":"Hydroxychloroquine in dermatology and beyond: recent update","volume":"11","author":"Sardana","year":"2020","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jfo.2022.09.033_bib0125","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2014.3459","article-title":"The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy","volume":"132","author":"Melles","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jfo.2022.09.033_bib0130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12016-010-8243-x","article-title":"Hydroxychloroquine: from malaria to autoimmunity","volume":"42","author":"Ben-Zvi","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jfo.2022.09.033_bib0135","doi-asserted-by":"crossref","first-page":"407","DOI":"10.55563\/clinexprheumatol\/1u36qt","article-title":"Guidelines on prescribing and monitoring antimalarials in rheumatic diseases: a systematic review","volume":"39","author":"Cramarossa","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jfo.2022.09.033_bib0140","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/acr.20133","article-title":"Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jfo.2022.09.033_bib0145","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/art.1780400817","article-title":"Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice","volume":"40","author":"Levy","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfo.2022.09.033_bib0150","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0161-6420(03)00409-3","article-title":"The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine","volume":"110","author":"Mavrikakis","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2022.09.033_bib0155","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1111\/j.1756-185X.2010.01478.x","article-title":"Retinopathy due to antimalarial drugs in patients with connective tissue diseases: are they so innocent?. A single center retrospective study: retinopathy, antimalarials and connective tissue disease","volume":"13","author":"Kobak","year":"2010","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jfo.2022.09.033_bib0160","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41433-020-1038-2","article-title":"Prevalence of hydroxychloroquine retinopathy using 2018 Royal College of Ophthalmologists diagnostic criteria","volume":"35","author":"Marshall","year":"2021","journal-title":"Eye"},{"key":"10.1016\/j.jfo.2022.09.033_bib0165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/IIO.0000000000000294","article-title":"Hydroxychloroquine retinopathy in the era of advanced imaging modalities","volume":"60","author":"Dahrouj","year":"2020","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.jfo.2022.09.033_bib0170","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","article-title":"Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)","volume":"123","author":"Marmor","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2022.09.033_bib0175","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2147\/OPTH.S66527","article-title":"Relative sensitivity and specificity of 10-2 visual fields, multifocal electroretinography, and spectral domain optical coherence tomography in detecting hydroxychloroquine and chloroquine retinopathy","volume":"8","author":"Browning","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jfo.2022.09.033_bib0180","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3346\/jkms.2017.32.3.522","article-title":"Frequency and clinical characteristics of hydroxychloroquine retinopathy in Korean patients with rheumatologic diseases","volume":"32","author":"Eo","year":"2017","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jfo.2022.09.033_bib0185","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ophtha.2010.11.017","article-title":"Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy","volume":"118","author":"Marmor","year":"2011","journal-title":"Ophthalmol"},{"key":"10.1016\/j.jfo.2022.09.033_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-019-09744-0","article-title":"Electrophysiological and SD-OCT findings in patients receiving chloroquine therapy in relation to cumulative dosage and duration of treatment","volume":"141","author":"Bertoli","year":"2020","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.jfo.2022.09.033_bib0195","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ophtha.2014.07.056","article-title":"Subjective and objective screening tests for hydroxychloroquine toxicity","volume":"122","author":"Cukras","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2022.09.033_bib0200","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/archophthalmol.2011.371","article-title":"Comparison of screening procedures in hydroxychloroquine toxicity","volume":"130","author":"Marmor","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2022.09.033_bib0205","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/art.41683","article-title":"American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 Joint Statement on hydroxychloroquine use with respect to retinal toxicity","volume":"73","author":"Rosenbaum","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jfo.2022.09.033_bib0210","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/s41433-020-01380-2","article-title":"The Royal College of Ophthalmologists recommendations on monitoring for hydroxychloroquine and chloroquine users in the United Kingdom (2020 revision): executive summary","volume":"35","author":"Yusuf","year":"2021","journal-title":"Eye"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551223000426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551223000426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:19:46Z","timestamp":1759259986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551223000426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0181551223000426"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2022.09.033","relation":{},"ISSN":["0181-5512"],"issn-type":[{"type":"print","value":"0181-5512"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening for toxic retinopathy due to antimalarial drugs in Tunisia","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2022.09.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}